m6A methylation in ferroptosis regulation: mechanisms, targets, and therapeutic interventions

Area of Science:

• Molecular Biology
• Cell Death Mechanisms
• Epigenetics

Background:

• N6-methyladenosine (m6A) RNA methylation is the most abundant eukaryotic mRNA modification, crucial for RNA metabolism via writers, erasers, and readers.
• Ferroptosis is a distinct form of cell death driven by lipid peroxidation and dependent on iron metabolism.
• Dysregulated iron metabolism, compromised antioxidant defenses, and lipid peroxidation are key factors in ferroptosis.

Purpose of the Study:

• To review recent advances in the crosstalk between m6A RNA methylation and ferroptosis.
• To identify potential therapeutic targets for various diseases by examining this relationship.
• To summarize current drugs and challenges in targeting m6A and ferroptosis pathways.

Main Methods:

• Review of existing literature on m6A RNA modification.
• Analysis of molecular mechanisms governing ferroptosis.
• Synthesis of studies investigating the regulation of ferroptosis-related proteins by m6A methylation.

Main Results:

• m6A methylation influences the expression of ferroptosis-related proteins, impacting tumorigenesis and pathogenesis.
• The interplay involves three biological axes: iron metabolism, redox balance, and lipid peroxidation dynamics.
• Numerous agents targeting m6A-related pathways and ferroptosis are under investigation.

Conclusions:

• The m6A-ferroptosis axis represents a significant area for understanding disease mechanisms.
• Targeting this axis holds promise for developing novel therapeutic strategies.
• Further research is needed to translate these findings into clinical applications.